SMTL ID : 2xhd.1

Crystal structure of N-((2S)-5-(6-fluoro-3-pyridinyl)-2,3-dihydro-1H- inden-2-yl)-2-propanesulfonamide in complex with the ligand binding domain of the human GluA2 receptor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

homo-dimer

Ligands

2 x GLU: GLUTAMIC ACID(Non-covalent)

GLU.1: 11 residues within 4Å: Chain A: Y.61, P.89, L.90, T.91, R.96, L.138, G.141, S.142, T.143, E.193, Y.220 15 PLIP interactions: 12 interactions with chain A, 3 Ligand-Ligand interactions Hydrophobic interactions: A:Y.61, A:L.138 Hydrogen bonds: A:P.89, A:T.91, A:T.91, A:S.142, A:T.143, A:T.143, A:E.193, E.1, E.1, E.1 Water bridges: A:L.138, A:E.193 Salt bridges: A:R.96 GLU.4: 11 residues within 4Å: Chain B: Y.61, P.89, L.90, T.91, R.96, L.138, G.141, S.142, T.143, E.193, Y.220 15 PLIP interactions: 12 interactions with chain B, 3 Ligand-Ligand interactions Hydrophobic interactions: B:Y.61, B:L.138 Hydrogen bonds: B:P.89, B:T.91, B:T.91, B:S.142, B:T.143, B:T.143, B:E.193, E.4, E.4, E.4 Water bridges: B:L.138, B:E.193 Salt bridges: B:R.96

5 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 4 residues within 4Å: Chain A: D.139, S.140, K.144, R.148 9 PLIP interactions: 9 interactions with chain A Hydrogen bonds: A:D.139, A:S.140 Water bridges: A:N.72, A:K.144, A:K.144, A:R.148, A:R.148 Salt bridges: A:K.144, A:R.148 SO4.3: 3 residues within 4Å: Chain A: R.148, W.159, R.163 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:R.148, A:R.163 SO4.6: 5 residues within 4Å: Chain B: A.63, D.139, S.140, K.144, R.148 9 PLIP interactions: 9 interactions with chain B Hydrogen bonds: B:D.139, B:S.140 Water bridges: B:K.144, B:K.144, B:E.145, B:E.145, B:R.148 Salt bridges: B:K.144, B:R.148 SO4.7: 1 residues within 4Å: Chain B: R.31 2 PLIP interactions: 2 interactions with chain B Water bridges: B:R.31 Salt bridges: B:R.31 SO4.8: 3 residues within 4Å: Chain B: R.148, W.159, R.163 4 PLIP interactions: 4 interactions with chain B Water bridges: B:W.159, B:R.163 Salt bridges: B:R.148, B:R.163

1 x 7T9: N-[(2S)-5-(6-FLUORO-3-PYRIDINYL)-2,3-DIHYDRO-1H-INDEN-2-YL]-2-PROPANESULFONAMIDE(Non-covalent)

7T9.5: 18 residues within 4Å: Chain A: K.104, P.105, M.107, S.108, S.217, K.218, G.219, L.239, S.242 Chain B: P.105, F.106, M.107, S.108, S.217, K.218, G.219, S.242, L.247 9 PLIP interactions: 4 interactions with chain B, 5 interactions with chain A Hydrophobic interactions: B:P.105, B:K.218, A:P.105, A:P.105, A:L.239 Water bridges: B:G.219, B:S.242, A:G.219 Hydrogen bonds: A:P.105

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ward, S.E. et al., Discovery of N-[(2S)-5-(6-Fluoro-3-Pyridinyl)-2,3-Dihydro-1H-Inden-2-Yl]-2-Propanesulfonamide, a Novel Clinical Ampa Receptor Positive Modulator. J.Med.Chem. (2010)

Release Date

2010-07-21

Peptides

GLUTAMATE RECEPTOR 2: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

GLUTAMATE RECEPTOR 2